Sweden
· Delayed Price · Currency is SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of SEK 14.71 billion. The enterprise value is 14.28 billion.
| Market Cap | 14.71B |
| Enterprise Value | 14.28B |
Important Dates
The last earnings date was Thursday, August 29, 2024.
| Earnings Date | Aug 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioArctic AB has 88.34 million shares outstanding. The number of shares has decreased by -0.65% in one year.
| Shares Outstanding | 88.34M |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | +1.74% |
| Owned by Insiders (%) | 34.03% |
| Owned by Institutions (%) | 51.78% |
| Float | 52.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 48.65 |
| PB Ratio | 15.92 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -161.73 |
| EV / Sales | 47.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -101.44 |
Financial Position
The company has a current ratio of 7.18, with a Debt / Equity ratio of 6.42.
| Current Ratio | 7.18 |
| Quick Ratio | 3.41 |
| Debt / Equity | 6.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.42 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.18% and return on invested capital (ROIC) is -5.95%.
| Return on Equity (ROE) | -9.18% |
| Return on Assets (ROA) | -5.33% |
| Return on Capital (ROIC) | -5.95% |
| Revenue Per Employee | 3.35M |
| Profits Per Employee | -980,889 |
| Employee Count | 88 |
| Asset Turnover | 0.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.48% in the last 52 weeks. The beta is -0.18, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | -47.48% |
| 50-Day Moving Average | 190.06 |
| 200-Day Moving Average | 218.02 |
| Relative Strength Index (RSI) | 46.35 |
| Average Volume (20 Days) | 230,803 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of SEK 301.85 million and -88.28 million in losses. Loss per share was -1.00.
| Revenue | 301.85M |
| Gross Profit | 234.67M |
| Operating Income | -94.68M |
| Pretax Income | -60.97M |
| Net Income | -88.28M |
| EBITDA | -76.03M |
| EBIT | -94.68M |
| Loss Per Share | -1.00 |
Balance Sheet
The company has 489.68 million in cash and 59.71 million in debt, giving a net cash position of 429.97 million or 4.87 per share.
| Cash & Cash Equivalents | 489.68M |
| Total Debt | 59.71M |
| Net Cash | 429.97M |
| Net Cash Per Share | 4.87 |
| Equity (Book Value) | 929.37M |
| Book Value Per Share | 10.46 |
| Working Capital | 886.27M |
Cash Flow
In the last 12 months, operating cash flow was -134.20 million and capital expenditures -6.54 million, giving a free cash flow of -140.75 million.
| Operating Cash Flow | -134.20M |
| Capital Expenditures | -6.54M |
| Free Cash Flow | -140.75M |
| FCF Per Share | -1.59 |
Margins
Gross margin is 77.74%, with operating and profit margins of -31.37% and -29.25%.
| Gross Margin | 77.74% |
| Operating Margin | -31.37% |
| Pretax Margin | -20.20% |
| Profit Margin | -29.25% |
| EBITDA Margin | -25.19% |
| EBIT Margin | -31.37% |
| FCF Margin | -46.63% |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.65% |
| Shareholder Yield | 0.65% |
| Earnings Yield | -0.60% |
| FCF Yield | -0.96% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |